The ESC 2019 CCS guidelines: Have we left our patients and scientific evidence behind?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31879185.
- Also identified by DOI 10.1016/j.ejim.2019.12.012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The ESC CCS 2019 guidelines recognize that successful management of anginal symptoms relies on effective therapy tailored to individual patient characteristics but do not provide any specific advice or clarity on how to utilize pharmacotherapy in order to achieve these goals. In this review, we are going to summarize and discuss the main points of disagreement.